Renalytix Plc

AIM:RENX Stock Report

Market Cap: UK£34.8m

Renalytix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:RENX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Dec 24BuyUK£2,437Fergus FlemingIndividual25,000UK£0.097
10 Dec 24BuyUK£2,125James McCulloughIndividual25,000UK£0.085
10 Dec 24BuyUK£1,955Julian BainesIndividual23,000UK£0.085
10 Dec 24BuyUK£4,450Howard DoranIndividual50,000UK£0.089
09 Dec 24BuyUK£4,000Howard DoranIndividual50,000UK£0.08
05 Dec 24BuyUK£3,997James McCulloughIndividual53,300UK£0.075
05 Dec 24BuyUK£3,402Christopher MillsIndividual48,601UK£0.07
04 Dec 24BuyUK£1,739Julian BainesIndividual23,989UK£0.072
01 Nov 24BuyUK£1,197,376Mount Sinai School Of Medicine, Endowment ArmCompany13,366,750UK£0.09
07 Oct 24SellUK£6,696Harwood Capital LLPCompany83,696UK£0.08
15 Aug 24SellUK£7,375Polar Capital Holdings PlcCompany50,000UK£0.15
14 Aug 24SellUK£3,637Polar Capital Holdings PlcCompany25,000UK£0.15
08 Aug 24SellUK£4,108Polar Capital Holdings PlcCompany28,000UK£0.15
26 Jun 24SellUK£44,625Heights Capital Management, Inc.Company350,000UK£0.13
25 Jun 24SellUK£23,870Heights Capital Management, Inc.Company175,000UK£0.14
18 Jun 24SellUK£17,250Heights Capital Management, Inc.Company100,000UK£0.17
14 Jun 24SellUK£173,264Heights Capital Management, Inc.Company980,000UK£0.18
13 Jun 24SellUK£32,600Heights Capital Management, Inc.Company200,000UK£0.16
12 Jun 24SellUK£16,300Heights Capital Management, Inc.Company100,000UK£0.16
07 Jun 24SellUK£11,963Heights Capital Management, Inc.Company72,500UK£0.17
06 Jun 24SellUK£41,250Heights Capital Management, Inc.Company250,000UK£0.17
05 Jun 24SellUK£16,500Heights Capital Management, Inc.Company100,000UK£0.16
04 Jun 24SellUK£16,500Heights Capital Management, Inc.Company100,000UK£0.17
03 Jun 24SellUK£53,788Heights Capital Management, Inc.Company325,000UK£0.17
31 May 24SellUK£11,422Heights Capital Management, Inc.Company75,000UK£0.15
30 May 24SellUK£4,125Heights Capital Management, Inc.Company25,000UK£0.17
29 May 24SellUK£6,562Heights Capital Management, Inc.Company37,500UK£0.17
28 May 24SellUK£4,500Heights Capital Management, Inc.Company25,000UK£0.18
22 May 24SellUK£1,900Heights Capital Management, Inc.Company10,000UK£0.19
16 May 24SellUK£23,000Heights Capital Management, Inc.Company100,000UK£0.23
15 May 24SellUK£41,247Heights Capital Management, Inc.Company175,000UK£0.24
14 May 24SellUK£2,450Heights Capital Management, Inc.Company10,000UK£0.24
09 May 24SellUK£36,208Heights Capital Management, Inc.Company97,212UK£0.50
07 May 24SellUK£10,800Heights Capital Management, Inc.Company40,000UK£0.27
06 May 24SellUK£12,580Heights Capital Management, Inc.Company23,412UK£0.54
02 May 24SellUK£47,250Heights Capital Management, Inc.Company175,000UK£0.27
01 May 24SellUK£16,060Heights Capital Management, Inc.Company73,002UK£0.22
30 Apr 24SellUK£37,040Heights Capital Management, Inc.Company166,998UK£0.22
29 Apr 24SellUK£2,400Heights Capital Management, Inc.Company10,000UK£0.24
24 Apr 24BuyUK£1,882,395Mount Sinai School Of Medicine, Endowment ArmCompany9,360,374UK£0.20

Insider Trading Volume

Insider Buying: RENX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RENX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies30,1160.00909%
Private Companies8,080,0862.44%
Hedge Funds17,946,2985.42%
General Public22,700,4706.85%
Individual Insiders52,057,01815.7%
VC/PE Firms52,406,04415.8%
Institutions177,985,98053.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 231.4%.

Top Shareholders

Top 25 shareholders own 88.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.3%
Mount Sinai School Of Medicine, Endowment Arm
37,346,476UK£3.9m57.1%2.13%
9.96%
Heights Capital Management, Inc.
33,000,000UK£3.5m754%0.62%
9.79%
James McCullough
32,420,096UK£3.4m16,800%no data
8.6%
Ruffer LLP
28,500,000UK£3.0m0%0.06%
8.31%
Polar Capital Holdings Plc
27,520,016UK£2.9m98.5%0.01%
5.86%
Jefferson River Capital
19,406,044UK£2.0m134%no data
5.72%
Unicorn Asset Management Ltd.
18,955,777UK£2.0m1,510%0.35%
5.42%
Pentwater Capital Management LP
17,946,298UK£1.9m116%0.05%
5.23%
UBS Asset Management AG
17,316,510UK£1.8m965%no data
4.46%
Harwood Capital LLP
14,777,019UK£1.6m0%0.16%
4.4%
Christopher Mills
14,561,345UK£1.5m0%no data
1.21%
NR Holdings Limited
4,001,187UK£420.1k0%no data
1.21%
DB Capital Venture Partners
4,000,001UK£420.0k0%100.0%
1.21%
Lombard Odier Asset Management (Europe) Ltd.
4,000,000UK£420.0k0%0.01%
1%
Pinnacle Associates, Ltd.
3,323,918UK£349.0k104%no data
0.77%
The Mccullough 2020 Irrevocable Trust
2,554,398UK£268.2k0%no data
0.61%
National Financial Services LLC, Asset Management Arm
2,022,398UK£212.4k-0.54%0.01%
0.56%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
1,860,070UK£195.3k-5.63%no data
0.56%
Julian Baines
1,848,700UK£194.1k0%no data
0.55%
Oliver Sterling
1,805,236UK£189.6k0%no data
0.46%
Gilder Gagnon Howe & Co. LLC
1,522,216UK£159.8k0%no data
0.38%
Stifel Asset Management Corp.
1,255,220UK£131.8k-11.3%no data
0.34%
Barclays Bank PLC, Wealth and Investment Management Division
1,118,619UK£117.5k154%no data
0.34%
Levin Capital Strategies, L.P.
1,110,000UK£116.6k0%0.01%
0.33%
Stockinvest Limited
1,105,000UK£116.0k5.24%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 01:35
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Renalytix Plc is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anita DushyanthBerenberg
Mark MassaroBTIG
David WestenbergGuggenheim Securities, LLC